Company intelligence / Profile preview

Companion Dx Reference Lab

Houston, Texas, United Statestxs.uscourts.gov ↗

Ownership: Private
Employees: ~66
Development stage: Other

Overview

Provides integrated genomic diagnostic and decision-support services including next-generation sequencing, pharmacogenomics, and therapeutic drug monitoring to support personalized medicine. Operates CLIA-certified high-complexity labs with a focus on actionable clinical intelligence for physicians from tumor diagnosis through treatment selection.[1][2][4][9] No clinical trial results as it does not develop drugs.

Therapeutic areas: OncologyOther
Modalities: Diagnostic test (Next-generation sequencing)Pharmacogenomics assayTherapeutic drug monitoring assay
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Companion Dx Reference Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Companion Dx Reference Lab.

Explore the full profile